<DOC>
	<DOC>NCT01553890</DOC>
	<brief_summary>The aim is to find the presence of anti vitamin D antibodies in scleroderma patients and compare with control. A second goal is anti vitamin D levels in serum of scleroderma patients in relation to the clinical manifestations of the disease.</brief_summary>
	<brief_title>Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples</brief_title>
	<detailed_description>Blood samples from 30 scleroderma patients compared to 30 healthy peoples to reach the target of variation of the blood level vitamin D antibody between this groups</detailed_description>
	<mesh_term>Scleroderma, Systemic</mesh_term>
	<mesh_term>Scleroderma, Diffuse</mesh_term>
	<mesh_term>Scleroderma, Localized</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>study group 1. patients with SSc 2. age 18 years old and older 3. sign ICF control group healthy people</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>SSc= scleroderma</keyword>
	<keyword>ICF+ informed consent form</keyword>
	<keyword>age 18 to 85</keyword>
	<keyword>healthy</keyword>
</DOC>